Orion enters into exclusive agreement with Jemincare for novel non-opioid drug candidate for the treatment of pain Read more
Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis Read more
Novartis receives European Commission approval for Jakavi to be the first post-steroid treatment for acute and chronic graft-versus-host disease Read more
Algernon Pharmaceuticals Announces Last Patient Treated in Phase 2 Study of IPF and Chronic Cough Read more
Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus Auto-Injector Read more
Apnimed Announces $62.5 Million Series C Financing to Advance Development of Novel Pharmaceutical Treatments for Obstructive Sleep Apnea (OSA) and Related Sleep Disorders Read more
CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development Read more
Novavax Requests Expanded Authorization of Nuvaxovid COVID-19 Vaccine to Adolescents Aged 12 through 17 Years in Great Britain Read more
Novartis Kymriah receives EC approval as first CAR-T cell therapy for adults with relapsed or refractory follicular lymphoma Read more